Impact of methicillin resistance on clinical features and outcomes of infective endocarditis due to Staphylococcus aureus

被引:12
作者
Hsu, RB
Chu, SH
机构
[1] Natl Taiwan Univ Hosp, Coll Med, Dept Surg, Taipei 100, Taiwan
[2] Far Eastern Mem Hosp, Taipei, Taiwan
关键词
infective endocarditis; Staphylococcus aureus; methicillin resistance;
D O I
10.1097/00000441-200409000-00003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. This study sought to determine the impact of methicillin resistance on clinical features and outcomes in patients with Staphylococcus aureus (SA) infective endocarditis (IE). Methods: Retrospective chart review. Univariate and forward stepwise logistic regressions were conducted to determine which factors significantly affected death and systemic embolism. Results: From October 1995 to April 2002, 57 patients with a definite diagnosis of IE caused by SA were included: 28 cases of methicillin-sensitive SA infection and 29 methicillin-resistant SA (MRSA) infection. Patients with MRSA infection are more likely to have old age, underlying diseases, history of hospitalization within the last 6 months, nosocomial infection, and antibiotic use within the last 3 months. Patients with MRSA infection had clinical presentation of less systemic embolism and more sepsis and had a higher 3-month mortality rate. Methicillin resistance is an independent positive predictor of death and a negative predictor of systemic embolism. Conclusions: MRSA became a dominant cause of SA IE. Although it caused a lower incidence of systemic embolism, MRSA infection had a higher mortality rate because of sepsis.
引用
收藏
页码:150 / 155
页数:6
相关论文
共 32 条
[1]  
BISHARA J, 2001, CLIN INFECT DIS, P43
[2]   Infective endocarditis -: A prospective study at the end of the twentieth century -: New predisposing conditions, new etiologic agents, and still a high mortality [J].
Bouza, E ;
Menasalvas, A ;
Muñoz, P ;
Vasallo, FJ ;
Moreno, MD ;
Fernández, MAG .
MEDICINE, 2001, 80 (05) :298-307
[3]   Changing patient characteristics and the effect on mortality in endocarditis [J].
Cabell, CH ;
Jollis, JG ;
Peterson, GE ;
Corey, GR ;
Anderson, DJ ;
Sexton, DJ ;
Woods, CW ;
Reller, LB ;
Ryan, T ;
Fowler, VG .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (01) :90-94
[4]   A prospective multicenter study of Staphylococcus aureus bacteremia -: Incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance [J].
Chang, FY ;
MacDonald, BB ;
Peacock, JE ;
Musher, DM ;
Triplett, P ;
Mylotte, JM ;
O'Donnell, A ;
Wagener, MM ;
Yu, VL .
MEDICINE, 2003, 82 (05) :322-332
[5]   STAPHYLOCOCCUS-AUREUS ENDOCARDITIS - A REVIEW OF 119 CASES [J].
ESPERSEN, F ;
FRIMODTMOLLER, N .
ARCHIVES OF INTERNAL MEDICINE, 1986, 146 (06) :1118-1121
[6]  
Fowler VG, 1999, CLIN INFECT DIS, V28, P106
[7]  
Gentry CA, 1997, PHARMACOTHERAPY, V17, P990
[8]   Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus [J].
Harbarth, S ;
Rutschmann, O ;
Sudre, P ;
Pittet, D .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (02) :182-189
[9]   Neurologic manifestations of infective endocarditis -: A 17-year experience in a teaching hospital in Finland [J].
Heiro, M ;
Nikoskelainen, J ;
Engblom, E ;
Kotilainen, E ;
Marttila, R ;
Kotilainen, P .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (18) :2781-2787
[10]   Changing profile of infective endocarditis -: Results of a 1-year survey in France [J].
Hoen, B ;
Alla, F ;
Selton-Suty, C ;
Béguinot, I ;
Bouvet, A ;
Briançon, S ;
Casalta, JP ;
Danchin, N ;
Delahaye, F ;
Etienne, J ;
Le Moing, V ;
Leport, C ;
Mainardi, JL ;
Ruimy, R ;
Vandenesch, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (01) :75-81